These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8728650)

  • 41. Structure-based design for high-hanging vaccine fruits.
    Back JW; Langedijk JP
    Adv Immunol; 2012; 114():33-50. PubMed ID: 22449777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of structure in antibody cross-reactivity between peptides and folded proteins.
    Craig L; Sanschagrin PC; Rozek A; Lackie S; Kuhn LA; Scott JK
    J Mol Biol; 1998 Aug; 281(1):183-201. PubMed ID: 9680484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory.
    Naruse H; Ogasawara K; Takami K; Kajino K; Gotohda T; Itoh Y; Miyazaki T; Good RA; Onoè K
    Vaccine; 1994 Jul; 12(9):776-82. PubMed ID: 7526571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthetic peptides for production of antibodies that recognize intact proteins.
    Grant GA
    Curr Protoc Immunol; 2003 Aug; Chapter 9():Unit 9.2. PubMed ID: 18432915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.
    Martineau P; Guillet JG; Leclerc C; Hofnung M
    Gene; 1992 Apr; 113(1):35-46. PubMed ID: 1373395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epitope discovery and their use in peptide based vaccines.
    Dudek NL; Perlmutter P; Aguilar MI; Croft NP; Purcell AW
    Curr Pharm Des; 2010; 16(28):3149-57. PubMed ID: 20687873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyvalent synthetic vaccines: relationship between T epitopes and immunogenicity.
    Jolivet M; Lise L; Gras-Masse H; Tartar A; Audibert F; Chedid L
    Vaccine; 1990 Feb; 8(1):35-40. PubMed ID: 1690488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential of plant virus vectors for vaccine production.
    Yusibov V; Rabindran S; Commandeur U; Twyman RM; Fischer R
    Drugs R D; 2006; 7(4):203-17. PubMed ID: 16784246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and in vitro T-cell immunogenicity of conjugates with dual specificity: attachment of epitope peptides of 16 and 38 kDa proteins from Mycobacterium tuberculosis to branched polypeptide.
    Wilkinson KA; Vordermeier H; Wilkinson RJ; Ivanyi J; Hudecz F
    Bioconjug Chem; 1998; 9(5):539-47. PubMed ID: 9736487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.
    Oseroff C; Sette A; Wentworth P; Celis E; Maewal A; Dahlberg C; Fikes J; Kubo RT; Chesnut RW; Grey HM; Alexander J
    Vaccine; 1998 May; 16(8):823-33. PubMed ID: 9627940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction of synthetic immunogens: use of T- and B-cell epitopes of CS and RESA proteins of Plasmodium falciparum.
    Ritu G; Rao DN
    Vaccine; 1992; 10(11):761-5. PubMed ID: 1279906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants.
    Cañizares MC; Lomonossoff GP; Nicholson L
    Expert Rev Vaccines; 2005 Oct; 4(5):687-97. PubMed ID: 16221070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solution conformation of an immunogenic peptide derived from the principal neutralizing determinant of the HIV-2 envelope glycoprotein gp125.
    Campbell AP; Sykes BD; Norrby E; Assa-Munt N; Dyson HJ
    Fold Des; 1996; 1(2):157-65. PubMed ID: 9079375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of MHC binding peptides and epitopes from alfalfa mosaic virus.
    Gomase VS; Kale KV; Chikhale NJ; Changbhale SS
    Curr Drug Discov Technol; 2007 Aug; 4(2):117-215. PubMed ID: 17691913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA
    Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses.
    Jegerlehner A; Tissot A; Lechner F; Sebbel P; Erdmann I; Kündig T; Bächi T; Storni T; Jennings G; Pumpens P; Renner WA; Bachmann MF
    Vaccine; 2002 Aug; 20(25-26):3104-12. PubMed ID: 12163261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of conformational mimetics of conserved Streptococcus pyogenes minimal epitope as vaccine candidates.
    Zhong W; Skwarczynski M; Toth I
    Curr Drug Deliv; 2009 Oct; 6(5):520-7. PubMed ID: 19863488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase.
    Reynolds SR; Dahl CE; Harn DA
    J Immunol; 1994 Jan; 152(1):193-200. PubMed ID: 7504709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.